Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The Latin American heart valve device market will experience robust growth, largely driven by an expanding patient pool, improving access to treatment, and rising adoption of THV devices through 2027.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Latin America across a 10-year period.
All segments of the heart valve device market in Latin America continue to expand.
Which device segments are the fastest growing and why?
What is the degree of penetration of heart valve procedures into the eligible patient population?
Continued adoption of THV—particularly TAVR—will drive growth of the Latin American heart valve device market.
What factors are driving adoption of TAVR in Latin America and do they vary by country?
How much does the high cost of TAVR impact adoption in Latin America?
While Latin America has been experiencing economic struggles, there is a high degree of focus on establishing universal health care.
How have economic shifts affected the heart valve device market?
Have efforts to establish universal health care impacted the heart valve device market?
What recent reimbursement policy changes have taken place and how do they affect market revenue?
How does the competitive landscape differ in the Latin American heart valve device market compared to the rest of the world?
What are the local competitors and how do their presence differ by country?
What have MNCs done to encourage the uptake of their premium-priced devices, especially TAVR devices?
What products under development make competitors more of a threat to established players?
Already a Client? Log in to access this report.
Erik J. Bracciodieta is a senior analyst within the Cardiovascular Medtech Insights team, specializing in cardiac rhythm management and structural heart closure device markets, as well as medical device pricing and regulations in Japan. Erik holds a Master's degree in Biotechnology from the University of Toronto. Follow Erik on Twitter: @ErikB_DRG.